Redesign Science is a computational chemistry company building a best-in-class solution for early-stage small molecule drug discovery. Driven by strategic partnerships, Redesign Science collaborates with Biotech and Pharma firms for milestone-driven research. Each relationship initiated with Redesign Science examines missed opportunities in protein mutation development.
With a vast quantity of therapeutic-based professionals in their practice, the pharmaceutical industry has a tendency to produce a systematic approach to both visual and corporate representation of a brand. Through the study of similar competitors in their space and their approach to relationships, it was certain that Redesign Science would challenge how that approach needed to be handled moving forward. Relationship-driven qualities with larger corporations became their forte. As a result, the brand needed to represent these characteristics in a way that not only defined their approach, but also defined what they do in comparison to others in their industry.
The strategy called for large typographic elements that made materials easier for investors to understand, alongside visual representations of the many proteins studied for developing pharmaceutical drugs. With hundreds of different protein offsprings, the visual interpretation of these mutations are mimicked through kinetic typography and fluid motion graphics. Simplicity in aesthetic with a subtle nod to the coded programming used to make these new discoveries allows Redesign Science to showcase brand of both structural organization and energetic movement. Overall, Redesign Science has been developed to create an approachable interactive experience that educates those willing to be a part of their industry.
